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Introduction
Heart failure is a complex syndrome caused by 
various etiologies. Nearly 5 million patients in the
United States have heart failure symptoms. Despite
improvements in pharmacologic treatment, heart
failure is still associated with high mortality and
morbidity [1] and has become a major economic
burden worldwide. In patients with advanced heart
failure, about 30–50% have concurrent electrical
delay in the surface ECG, mainly in the form of left
bundle branch block [2]. Ventricular conduction
abnormalities cause interventricular and intraven-
tricular dyssynchronized contraction, further impairs
systolic function, decreases cardiac output, short-
ens diastolic filling time, increases left ventricular
end-systolic volume, and increases left ventricular
wall stress and mitral regurgitation [3]. Cardiac
resynchronization therapy (CRT) as an adjunctive
therapy for medically refractive heart failure with a
wide QRS interval has been established. CRT or
biventricular pacing places one pacing lead in the
cardiac veins via the coronary sinus, and the other
lead is placed at the septum using the conventional
right ventricular approach (Fig. 1). Biventricular
pacing synchronizes interventricular and intraven-
tricular activation and contraction in patients with
heart failure and interventricular conduction delay.
The MUSTIC and MIRACLE trials showed that re-
synchronization therapy could significantly increase
the distance walked in 6 minutes, improve the
quality-of-life score, treadmill exercise time and
left ventricular ejection fraction (LVEF), and reduce
left ventricular (LV) end-diastolic diameter and hos-
pitalization [4,5]. The Companion trial showed
that CRT with or without an implantable defibrilla-
tor significantly reduced the composite end point
of death from advanced chronic heart failure or
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hospitalization for advanced chronic heart failure
[6]. More recently, the CARE-HF trial showed that
CRT significantly reduced death and the combined
end point of death from any cause or hospitaliza-
tion for major cardiovascular events in patients
with NYHA class III or IV heart failure, QRS duration 
of 120 milliseconds or longer, and LVEF of 35% or
less [7]. Benefits of CRT have been found in both
ischemic and non-ischemic heart failure [8]. How-
ever, 20–30% of patients do not exhibit improve-
ments in cardiac function after CRT, and no
evidence of reverse remodeling has been shown
[9]. The prevalence of non-responders is higher
among patients with borderline prolonged QRS
duration (54%) than in patients with severe pro-
longed QRS duration (32%). Severe prolonged QRS
duration is defined as a QRS duration of greater
than 150 milliseconds [10]. For patients with left
ventricular systolic dysfunction, a LVEF of 35% or
less, ventricular dyssynchrony, QRS interval width
≥120 milliseconds, and medically refractive heart
failure, CRT has been established as an adjunctive
therapy. Echocardiography is a vital tool in the eval-
uation of cardiac function in patients before CRT
device implantation, in the assessment of CRT device
setting optimization, in the evaluation of treat-
ment efficacy, and in the prediction of favorable
responses.
Echocardiographic Assessment before
Implantation of CRT
Echocardiography is initially used to confirm and
assess the severity of LV dysfunction. Since patients
with left bundle branch block tend to have para-
doxical septal motion, the biplane Simpson method
is used to determine LV end-diastolic and systolic
volume, to detect regional wall motion abnormal-
ity, and to calculate LVEF. Pulsed wave Doppler is
used to measure stroke volume and cardiac output,
assess LV diastolic function, calculate diastolic filling
time, and detect the presence of diastolic mitral
regurgitation. Color flow imaging is used to evaluate
the severity of mitral regurgitation. The myocardial
performance index (Tei index) is another method
used to assess systolic and diastolic LV function.
Interventricular dyssynchrony represents the time
discordance between right ventricle and left ven-
tricle contraction. Pulsed wave Doppler of the right
and left ventricular pre-ejection period is determined
as the interval from Q to onset of right ventricular
(RV) outflow track and Q to onset of LV outflow
track (LVOT), which can also be used to determine
interventricular dyssynchrony. The difference be-
tween RV and LV pre-ejection period is normally
less than 40 milliseconds. A difference of greater
than 50 milliseconds is considered abnormal. If LV
A B
Fig. 1. Chest X-ray film of a patient (A) with dilated cardiomyopathy and (B) 4 years after cardiac resynchronization therapy.
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pre-ejection period is greater than 140 milliseconds,
it is considered prolonged [11]. The myocardial
performance index is calculated by subtracting the
LVOT ejection time from mitral valve closure to
opening time and then dividing by the LVOT ejec-
tion time. Decreases in myocardial performance
index represent improvements in both LV systolic
and diastolic function after CRT. Measuring the
time from onset of QRS to peak systolic velocity of
RV free wall and lateral LV basal segment in the
apical four chamber view, Doppler tissue imaging
can also be used to determine the presence of
interventricular dyssynchrony. Decreases in time
delay after CRT suggest improvements in interven-
tricular synchrony [12]. LV septal and posterior
wall motion recorded by M-mode echocardiogra-
phy is a method for determining LV intraventri-
cular dyssynchrony. A septal and posterior wall
contraction delay longer than 130 milliseconds is
considered to represent significant dyssynchrony.
Pulsed wave Doppler tissue imaging can be used
to determine the regional electromechanical delay
in intraventricular dyssynchrony by measuring the
time interval from onset of QRS to the time of peak
systolic myocardial velocity of LV segments at the
mitral annulus. The normal intraventricular delay is
less than 65 milliseconds. It has been shown that if
positioned at the site of longest electromechanical
delay, the benefit of LV pacing is maximal [13].
However, significant delay in the timing of regional
contraction among LV segments is not always
present in patients with a prolonged QRS interval.
Patients without significant dyssynchrony may
potentially be non-responders to CRT [14].
Optimization of the Atrioventricular
(AV) Interval and Interventricular
Interval after CRT
First-degree AV block is often seen in patients with
heart failure and prolonged QRS duration. AV pro-
longation may result in diastolic mitral regurgita-
tion, shortened diastolic filling of the left ventricle,
and reduced LV contractility. A hemodynamically
favorable AV delay should optimize both diastolic
filling and cardiac output [15]. A short AV delay
would reveal a truncated A wave. An optimal AV
interval places the end of the atrial filling wave at
the onset of isovolumic contraction. An optimal AV
interval can be achieved by the pulsed Doppler
mitral inflow method (Fig. 2) [16] or the aortic
velocity time integral method in patients receiving
CRT [17]. The optimal AV delay can be obtained
by the pulsed Doppler mitral inflow method and
the application of the Ritter formula. The aortic
velocity time integral method may provide a bet-
ter determinant of the optimal AV delay for CRT,
because it represents the direct systolic perform-
ance rather than the diastolic filling.
Sequential biventricular pacing could provide
greater synchrony than simultaneous biventricular
pacing. LV before RV pacing with optimal interven-
tricular delay may result in maximal hemodynamic
A B
Fig. 2. Doppler mitral flow (A) before and (B) after optimization of atrioventricular interval.
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improvement (Fig. 3). The stroke volume assess-
ment at the LVOT by echocardiography is the most
common way to evaluate interventricular optimiza-
tion. The average interval of the interventricular
delay is around 20 to 40 milliseconds [18].
A series of echocardiographic examinations
could be used to determine the occurrence of LV
reverse remodeling following CRT. When the biplane
Simpson method is used, LV reverse remodeling
was characterized by a decrease in LV volume and
an increase in LVEF. Significant LV end-systolic volume
reduction (22%) and increased LVEF (8%) were
observed in the majority of patients within 3–6
months [13,14].
CRT is an adjunctive therapy for patients with
medically refractive heart failure. Echocardiography
is the most useful technique for evaluating patients
before and after CRT.
Intraventricular Dyssynchrony
Characterized by premature contraction or late
contraction of LV segments, intraventricular dyssyn-
chrony results from delayed electrical conduction
and could lead to impaired LV systolic function. 
M-mode echocardiography can be used to deter-
mine the time difference in septal to posterior wall
Fig. 3. Optimization of interventricular delay by comparison
of aortic and pulmonary pre-ejection intervals.
Fig. 4. Septal–posterior wall motion
delay determined by parasternal M-
mode echocardiography.
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motion delay and is obtained by calculating the
difference between the time from onset of the 
Q wave to the initial peak posterior displacement
of the septum and the peak systolic anterior dis-
placement of the posterior wall (Fig. 4). After CRT,
septal–posterior wall motion delay decreased with
an improvement in LV function and clinical outcome
[19]. Two- and three-dimensional echocardiogra-
phy are also used to evaluate LV dyssynchrony and
provide a better spatial resolution, but are quite
time consuming. Normal intraventricular delay is
less than 65 milliseconds. However, in pulsed wave
Doppler tissue imaging, Q-Sm intervals between
LV segments of greater than 65 milliseconds are
not always present in patients with heart failure
and wide QRS intervals, and may be present 
in patients with heart failure and normal QRS 
intervals [14].
In patients with heart failure and prolonged
QRS duration, M-mode echocardiography, two-
dimensional echocardiography combined with
pulsed wave/continuous wave Doppler, and
Doppler tissue imaging play an important role
before, during and after CRT (Fig. 5). However,
Fig. 5. Q-Sm interval between left ventricu-
lar segments determined by two-dimensional
tissue Doppler imaging.
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there is no general agreement in the evaluation
criteria. Further research is needed in the echocar-
diographic evaluation of dyssynchrony.
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